Back To: Home

Our 2020 Media Kit is now available
Your gateway to the latest oncology news, trends and resources
Inside this issue:
November 2019
Investigational treatment for Friedreichís ataxia leads to significant improvement in patient scores...
by Kelsey Kaustinen
November 2019
Theragnostics makes moves on the prostate front...
by Mel J. Yeates
November 2019
Checking out the news in drug delivery advancements...
by Jeffrey Bouley
November 2019
Year three of the collaborative ASCB|EMBO meeting presents a wide variety of innovative cell biology research...
by Mel J. Yeates
Lonza webinar - "Paper to EBR in 9 Months: How a Strong Collaboration Leads to Project Success"
On Nov. 12, Lonza will host a free 60-minute webinar during which Nephron Pharmaceuticals will explain its decision to take a paperless approach to batch record management. Using paper-based workflows to record the wealth of information generated by each batch during pharmaceutical manufacturing is resource intensive, time consuming and can negatively impact the time-to-market for new therapeutics. Taking a collaborative approach, Nephron worked with Lonza to implement Lonza’s MODA-ES™ Electronic Batch Record Platform in just nine months, leading to increased operational efficiency and expanded product lines. To find out how to attend the webinar, click here.

Patent Docs: Sovereign immunity not absolute for states under the Eleventh Amendment
Kevin Noonan discusses a case in which the University of Texas sued Boston Scientific for patent infringement related to implantable drug-releasing biodegradable fibers. To read it, click here.

Editor's Focus:
November 2019
The very fact that we define results as positive or negative highlights our reluctance to accept change, that the story we have built in our heads may not fully reflect our reality.. [ more ]
by Randall C Willis

November 2019
Improving throughput and reliability in routine neurotoxicity testing.. [ more ]
by Brett Spangler of Lonza

November 2019
It seems there might be a trend away from crude and opportunistic tack-on merger and acquisition deals and toward more deliberate M&A deals that better fit companies' current and future needs, which would be welcome in an era when internal, organic R&D growth isn't what it used to be.. [ more ]
by Jeffrey Bouley

Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by Offenberger & White.